CURX Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Curanex Pharmaceuticals Inc (CURX) is not a good buy for a beginner, long-term investor at this time. The stock shows no strong positive catalysts, weak financial performance, and lacks significant trading or sentiment signals. Additionally, technical indicators and price trends suggest potential further downside in the short term.
The MACD is slightly positive but contracting, RSI is neutral at 73.608, and moving averages are converging, indicating no clear trend. The stock is trading near its pivot level of 0.464, with resistance at 0.532 and support at 0.396. The overall technical outlook is neutral to slightly bearish.
NULL identified. No recent news, no significant insider or hedge fund activity, and no congress trading data available.
The stock has shown consistent price declines in pre-market (-3.47%), regular market (-1.33%), and post-market (-3.64%). Broader market sentiment is also negative, with the S&P 500 down 1.79%. Financial performance is weak, with no revenue and significant net losses.
In Q3 2025, the company reported no revenue growth (0% YoY), net income of -954,059 (up 946.51% YoY, but still negative), and EPS of -0.04 (no improvement YoY). Gross margin remains at 0%. Overall, the financials indicate a struggling company with no clear growth trajectory.
No analyst ratings or price target changes available.
